Vanguard Group
AXNX

Vanguard Group’s Axonics, Inc. Common Stock AXNX Stock Holding History

Vanguard Group’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,064,595
Closed -$352M – 4349
2024
Q3 		$352M Buy
5,064,595
+23,301
+0.5% +$1.6M 0.01% 1232
2024
Q2 		$339M Sell
5,041,294
-564
-0% -$38K 0.01% 1196
2024
Q1 		$348M Sell
5,041,858
-218,972
-4% -$14.8M 0.01% 1197
2023
Q4 		$327M Sell
5,260,830
-1,484
-0% -$83K 0.01% 1233
2023
Q3 		$295M Sell
5,262,314
-72,029
-1% -$4.05M 0.01% 1218
2023
Q2 		$269M Buy
5,334,343
+157,380
+3% +$8.37M 0.01% 1306
2023
Q1 		$282M Buy
5,176,963
+313,680
+6% +$18.3M 0.01% 1252
2022
Q4 		$304M Buy
4,863,283
+789,810
+19% +$52.4M 0.01% 1169
2022
Q3 		$287M Buy
4,073,473
+991,055
+32% +$68.4M 0.01% 1162
2022
Q2 		$175M Buy
3,082,418
+268,555
+10% +$14.7M ﹤0.01% 1511
2022
Q1 		$176M Sell
2,813,863
-88,833
-3% -$4.79M ﹤0.01% 1627
2021
Q4 		$163M Buy
2,902,696
+25,166
+0.9% +$1.54M ﹤0.01% 1719
2021
Q3 		$187M Buy
2,877,530
+1,044,453
+57% +$71.3M ﹤0.01% 1649
2021
Q2 		$116M Buy
1,833,077
+321,351
+21% +$19M ﹤0.01% 1920
2021
Q1 		$90.5M Buy
1,511,726
+105,639
+8% +$5.74M ﹤0.01% 2006
2020
Q4 		$70.2M Buy
1,406,087
+40,980
+3% +$1.92M ﹤0.01% 2027
2020
Q3 		$69.7M Buy
1,365,107
+155,504
+13% +$6.49M ﹤0.01% 1851
2020
Q2 		$42.5M Buy
1,209,603
+388,713
+47% +$13.4M ﹤0.01% 2081
2020
Q1 		$20.9M Buy
820,890
+33,762
+4% +$1M ﹤0.01% 2260
2019
Q4 		$21.8M Buy
787,128
+218,287
+38% +$5.21M ﹤0.01% 2497
2019
Q3 		$15.3M Buy
568,841
+51,964
+10% +$1.81M ﹤0.01% 2601
2019
Q2 		$21.2M Buy
516,877
+141,068
+38% +$3.97M ﹤0.01% 2485
2019
Q1 		$9M Buy
375,809
+76,881
+26% +$1.39M ﹤0.01% 2881
2018
Q4 		$4.52M Buy
+298,928
New +$4.45M ﹤0.01% 3122

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vanguard Group's AXNX Position: Q4 2024 in Review

Vanguard Group sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 5,064,595 shares — an estimated $352M sold.

Vanguard Group first reported a position in AXNX in Q4 2018 and held it in 24 quarters. The position peaked at $352M in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Vanguard Group reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Vanguard Group sold 5,064,595 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $352M.
  • Vanguard Group first reported a position in Axonics, Inc. Common Stock in Q4 2018 and held it in 24 quarters.
  • Vanguard Group's Axonics, Inc. Common Stock position peaked at $352M in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Vanguard Group's 13F filing for Q4 2024, filed 11 Feb 2025.